|
|
| Antalgiques > Etude de marché sectorielle |
|
|
|
|
€ 240,00 |
Editeur
: |
Snapshots International |
Langue
: |
Anglais |
Date de publication : |
Avril 2007 |
Taille du document : |
12 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (1) |
|
|
|
| 48 pages | Décembre 2006 | Anglais
|
|
|
| Main
focus: |
hospital,emergency,hospitals,medical hospital,...
|
| Research
focus: |
competition analysis,market definition, |
| Geographic
focus: |
usa,india,mexico,france,united kingdom |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
OTC Analgesics in Germany
10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Analgesics in Germany' Major Market Profile report offers an introduction to the market.
It is c.
10 pages long and provides a top line overview of sales trends |
198,00 €
|
| |
| |
Event Analysis and Response Service: Cox-2s - Cox-2 Crisis Dents Big Pharma Confidence
95 pages | Juin 2005 |
IntroductionOn 30th September 2004, Merck withdrew its blockbuster drug Vioxx from the global market after trial data reinforced the suspicion that it increased the risk of cardiovascular events.
V |
9 120,00 €
|
| |
| |
Pain Management
459 pages | Janvier 2006 |
This report analyzes the worldwide markets for Pain Management in Millions of US$.
The specific product segments analyzed are Pain Management Pharmaceuticals, Pain Management Devices, and Pain Mana |
3 091,00 €
|
| |
| |
Commercial Insight: Neuropathic Pain - A Plethora of Patient Segmentation and Product Differentiation Opportunities
131 pages | Juillet 2006 |
IntroductionNeurontin (gabapentin) has finally been knocked off the top spot as a result of fierce generic incursion.
However, Pfizer's follow-on Lyrica (pregabalin), Lilly's Cymbalta (duloxetine) |
12 160,00 €
|
| |
| |
US Analgesics 2006
14 pages | Septembre 2006 |
US Analgesics 2006 provides 2005 year-end market size data, with 2006 estimates, 4 years of historical data and five-year forecasts.
The Snapshots report gives an instant overview of the US analges |
240,00 €
|
| |
| |
Analgesics
651 pages | Janvier 2006 |
This report analyzes the worldwide markets for Analgesics in Millions of US$.
The major product segments analyzed are Internal Analgesics, and External Analgesics.
The sub-product segments discu |
2 699,00 €
|
| |
| |
US External Analgesics 2005
12 pages | Juin 2005 |
Snapdata's US External Analgesics 2005 report provides 2004 year-end market data, with 2005 estimates and five-year forecasts.
The report gives an instant overview of the US external analgesic mark |
240,00 €
|
| |
| |
World Analgesic Market, 2005-2015
1 pages | Mai 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Opioid Abuse - Hooked on Generics?
42 pages | Décembre 2005 |
IntroductionOpioid abuse is a growing medical challenge, yet few developments have been made in its treatment in recent years.
The market requires clarification of the goals of therapy - to remove |
3 230,00 €
|
| |
| |
US Internal Analgesics 2005
13 pages | Juin 2005 |
Snapdata's US Internal Analgesics 2005 report provides 2004 year-end market data, with 2005 estimates and five-year forecasts.
The report gives an instant overview of the US internal analgesic mark |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
Snapdata's Snapshots UK Analgesics 2007 provides 2005 year-end market size data, with 2006 estimates, 4 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the UK analgesic market, and covers non-prescription adult oral analgesics, paediatric analgesics, topical analgesics and others. Market value is based on grocery and pharmacy sales. The data is supplied in both graphical and tabular format for ease of interpretation and analysis. The Snapshots UK Analgesics 2007 forms part of Snapdata's OTC Pharmaceuticals industry coverage.
Why buy this report?
· Contains time-saving industry data overview of market size, shares, and 5 year forecasts
· Market size and shares data measured by both value and volume
· Fully sourced data points
· Easy to follow format
· Good starting point for the initial stages of research
|
|
Page 3 - Snapshots Executive Summary
Page 4 - Category Definitions
Page 5 - Market Size by Value (2002-2006)
Page 6 - Market Segmentation by Value (2005)
Page 7 - Market Shares (Adult Oral Analgesics) by Value
Page 8 - Company Websites (Main Players)
Page 9 - Market Forecast by Value (2007-2011)
Page 10 - Socio-Economic Data for UK
Page 11 - Snapshots Sources for Further Research
|
|
|
PPLSEN
|
|
|
|
|
